» Articles » PMID: 25902182

Digitomotography in Parkinson's Disease: a Cross-sectional and Longitudinal Study

Overview
Journal PLoS One
Date 2015 Apr 23
PMID 25902182
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Motor symptoms in Parkinson's disease (PD) are usually assessed with semi-quantitative tests such as the Unified PD Rating Scale (UPDRS) which are limited by subjectivity, categorical design, and low sensitivity. Particularly bradykinesia as assessed e.g. with speeded index finger tapping exhibits low validity measures. This exploratory study set out to (i) assess whether force transducer-based objective and quantitative analysis of motor coordination in index finger tapping is able to distinguish between PD patients and controls, and (ii) assess longitudinal changes. Sixteen early-stage and 17 mid-stage PD patients as well as 18 controls were included in the cross-sectional part of the study; thirteen, 16 and 16 individuals of the respective groups agreed in a reassessment 12 months later. Frequency, force, rhythmicity, regularity and laterality of speeded and metronome paced tapping were recorded by digitomotography using a quantitative motor system ("Q-Motor"). Analysis of cross-sectional data revealed most consistent differences between PD patients and controls in variability of tap performance across modalities assessed. Among PD patients, variability of taps and the ability to keep a given rhythm were associated with UPDRS motor and finger tapping scores. After 12 months, laterality parameters were reduced but no other parameters changed significantly. This data suggests that digitomotography provides quantitative and objective measures capable to differentiate PD from non-PD in a small cohort, however, the value of the assessment to track PD progression has to be further evaluated in larger cohorts of patients.

Citing Articles

Parkinsonian Hand or Clinician's Eye? Finger Tap Bradykinesia Interrater Reliability for 21 Movement Disorder Experts.

Williams S, Wong D, Alty J, Relton S J Parkinsons Dis. 2023; 13(4):525-536.

PMID: 37092233 PMC: 10357208. DOI: 10.3233/JPD-223256.


Developing and assessing a new web-based tapping test for measuring distal movement in Parkinson's disease: a Distal Finger Tapping test.

Akram N, Li H, Ben-Joseph A, Budu C, Gallagher D, Bestwick J Sci Rep. 2022; 12(1):386.

PMID: 35013372 PMC: 8748736. DOI: 10.1038/s41598-021-03563-7.


The First Frontier: Digital Biomarkers for Neurodegenerative Disorders.

Ray Dorsey E, Papapetropoulos S, Xiong M, Kieburtz K Digit Biomark. 2020; 1(1):6-13.

PMID: 32095743 PMC: 7015357. DOI: 10.1159/000477383.


Application of Quantitative Motor Assessments in Friedreich Ataxia and Evaluation of Their Relation to Clinical Measures.

Hohenfeld C, Dogan I, Schubert R, Didszun C, Schols L, Synofzik M Cerebellum. 2019; 18(5):896-909.

PMID: 31441004 DOI: 10.1007/s12311-019-01073-x.


Potential Markers of Progression in Idiopathic Parkinson's Disease Derived From Assessment of Circular Gait With a Single Body-Fixed-Sensor: A 5 Year Longitudinal Study.

Encarna Mico-Amigo M, Kingma I, Heinzel S, Rispens S, Heger T, Nussbaum S Front Hum Neurosci. 2019; 13:59.

PMID: 30837857 PMC: 6389786. DOI: 10.3389/fnhum.2019.00059.


References
1.
Hobert M, Niebler R, Meyer S, Brockmann K, Becker C, Huber H . Poor trail making test performance is directly associated with altered dual task prioritization in the elderly--baseline results from the TREND study. PLoS One. 2011; 6(11):e27831. PMC: 3218043. DOI: 10.1371/journal.pone.0027831. View

2.
Beck A, Steer R, Ball R, Ranieri W . Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess. 1996; 67(3):588-97. DOI: 10.1207/s15327752jpa6703_13. View

3.
Maetzler W, Mancini M, Liepelt-Scarfone I, Muller K, Becker C, van Lummel R . Impaired trunk stability in individuals at high risk for Parkinson's disease. PLoS One. 2012; 7(3):e32240. PMC: 3311622. DOI: 10.1371/journal.pone.0032240. View

4.
Tabrizi S, Scahill R, Owen G, Durr A, Leavitt B, Roos R . Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol. 2013; 12(7):637-49. DOI: 10.1016/S1474-4422(13)70088-7. View

5.
HOEHN M, Yahr M . Parkinsonism: onset, progression and mortality. Neurology. 1967; 17(5):427-42. DOI: 10.1212/wnl.17.5.427. View